II. Class
- Anti-retroviral agent
- Fusion Inhibitor
III. Indications
- Treatment-experienced patients
- Limited use in clinical practice
IV. Mechanism
- Blocks HIV to chemokine receptor binding on CD4 cells
V. Adverse Effects
- Injection site pain and reaction (common)
- Eosinophilic Hypersensitivity Reaction (<1%)
- Neutropenia
- Increased risk of Bacterial Pneumonia
Images: Related links to external sites (from Bing)
Related Studies
| fuzeon (on 1/1/2017 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
| FUZEON 90 MG VIAL | $57.53 each | |
